Clinical Trial Update: To Assess Allisartan Isoproxil/Sustained-Release Indapamide in Patients With Essential Hypertension Uncontrolled With Allisartan Isoproxil [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a fixed-dose combination of Allisartan Isoproxil and sustained-release Indapamide for essential hypertension uncontrolled wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Allisartan Isoproxil (allisartan isoproxil)
• Indapamide (sustained-release) (indapamide)

Snippet

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED